Mediclinic International PLC (MDC) Receives Consensus Rating of “Hold” from Analysts
Shares of Mediclinic International PLC (LON:MDC) have been assigned a consensus rating of “Hold” from the seven analysts that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is GBX 849 ($10.74).
A number of equities analysts recently issued reports on MDC shares. Investec reissued a “buy” rating on shares of Mediclinic International PLC in a report on Friday, April 28th. Credit Suisse Group lowered their price target on Mediclinic International PLC from GBX 1,045 ($13.22) to GBX 985 ($12.46) and set an “outperform” rating on the stock in a report on Thursday, February 23rd. Macquarie lowered Mediclinic International PLC to a “neutral” rating and lowered their price target for the stock from GBX 860 ($10.88) to GBX 770 ($9.74) in a report on Tuesday, April 4th. Jefferies Group LLC lowered Mediclinic International PLC to an “underperform” rating and raised their price target for the stock from GBX 639 ($8.08) to GBX 658 ($8.32) in a report on Monday, February 20th. Finally, Citigroup Inc. lowered their price target on Mediclinic International PLC from GBX 890 ($11.26) to GBX 860 ($10.88) and set a “neutral” rating on the stock in a report on Wednesday, February 22nd.
Mediclinic International PLC (LON MDC) traded up 1.06% on Tuesday, reaching GBX 812.50. 1,029,301 shares of the company were exchanged. Mediclinic International PLC has a 12-month low of GBX 666.50 and a 12-month high of GBX 1,125.00. The stock has a 50 day moving average of GBX 816.22 and a 200 day moving average of GBX 772.84. The firm’s market capitalization is GBX 5.99 billion.
The firm also recently disclosed a dividend, which will be paid on Monday, July 31st. Shareholders of record on Thursday, June 22nd will be issued a GBX 4.70 ($0.06) dividend. This represents a yield of 0.58%. The ex-dividend date is Thursday, June 22nd. This is a positive change from Mediclinic International PLC’s previous dividend of $3.20.
ILLEGAL ACTIVITY NOTICE: This piece of content was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/06/13/mediclinic-international-plc-mdc-receives-consensus-rating-of-hold-from-analysts.html.
About Mediclinic International PLC
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.